Abstract:Objective Extensive studies demonstrated that diabetes abolished the effectiveness of cardioprotection by ischaemic preconditioning (IPC) during ischaemia/reperfusion. Transient receptor potential vanilloid type 1 (TRPV1) contributes to the cardioprotective effect of IPC against ischaemia/reperfusion injury through the release of calcitonin gene-related peptide (CGRP) and substance P (SP). Our previous study found that the expression of TRPV1 receptor and the level of CGRP and SP were decreased in diabetic hearts. However, whether the underlying mechanism of the loss of cardioprotection by IPC during diabetes is associated with the impairment of TRPV1 receptor remains largely unknown. Methods Isolated hearts from streptozotocin-induced diabetic rats and normal control rats were subjected to 30 min of global ischaemia followed by 40 min of reperfusion. IPC was initiated by 3 cycles of 5 min of global ischaemia and 5 min of reperfusion before prolonged ischaemia in the presence or absence of CGRP or SP receptor inhibitor. Diabetic and normal control hearts were also pre-treated with CGRP or SP before prolonged ischaemia. Cardiac function parameters including left ventricular end-diastolic pressure, left ventricular developed pressure, maximum rise/fall rate of LV pressure, coronary flow and rate-pressure product and myocardial injury markers including creatine kinase (CK) and cardiac troponin I (cTnI) in coronary effluent were monitored during the experiment. In addition, CGRP and SP release in coronary effluent during IPC were measured in the presence or absence of TRPV1 receptor inhibitors. Results IPC effectively protected the hearts against ischaemia/reperfusion injury by improving the recovery of cardiac function and lowering CK and cTnI release in coronary effluent in normal control rats, but not in diabetic rats. Pre-treatment with CGRP or SP significantly increased the recovery of cardiac function and decreased CK and cTnI release during ischaemia/reperfusion in both normal control and diabetic rats, and these cardioprotection of pre-treatment with CGRP or SP in normal control rats were comparable to those of IPC. In addition, inhibition of CGRP or SP receptor essentially abolished the cardiac protective effects of IPC in normal control rats, but not in diabetic rats. IPC resulted in significant increase of CGRP and SP release in coronary effluent of normal control hearts, and which were effectively inhibited by TRPV1 receptor inhibitor, capsazepine or ruthenium red. However, IPC had no effects on CGRP and SP release in coronary effluent of diabetic hearts in the presence or absence of capsazepine or ruthenium red. Conclusions Cardioprotection by IPC against ischaemia/reperfusion injury is lost during diabetes, and their underlying mechanism is partly associated with the decreased CGRP and SP release due to the impairment of TRPV1 receptor in diabetic hearts.

Transient receptor potential vanilloid 1 is involved in the transfer of cardioprotection by remote limb ischemic postconditioning in rats

TRPV1 Activation is Involved in the Cardioprotection of Remote Limb Ischemic Postconditioning in Ischemia-Reperfusion Injury Rats.

Abstract T P84: Neuroprotective Effect of Probenecid in a Rat Model of Transient Global Cerebral Ischemia-Reperfusion

Inhibition of Mitochondrial Permeability Transition Pore Opening Mediated by Kappa‐opioid Receptor in Cardioprotection by Remote Preconditioning

Decreased expression of transient receptor potential vanilloid 1 impaires the postischemic recovery of diabetic mouse hearts.

TRPV1 activation exacerbates hypoxia/reoxygenation-induced apoptosis in H9C2 cells via calcium overload and mitochondrial dysfunction.

Cardioprotection by ischemic postconditioning is lost in isolated perfused heart from diabetic rats: Involvement of transient receptor potential vanilloid 1, calcitonin gene-related peptide and substance P

TRPV1 Activation Exacerbates Hypoxia/Reoxygenation-Induced Apoptosis in H9C2 Cells via Calcium Overload and Mitochondrial Dysfunction

Up-regulation of Calcitonin Gene-Related Peptide Protects Streptozotocin-Induced Diabetic Hearts from Ischemia/reperfusion Injury

Remote Ischemic Postconditioning Alleviates Cerebral Ischemic Injury by Attenuating Endoplasmic Reticulum Stress-Mediated Apoptosis

Effect of remote ischemic postconditioning on cerebral ischemia/reperfusion injury in rats

Nerve Growth Factor Rescues Diabetic Mice Heart after Ischemia/Reperfusion Injury Via Up-Regulation of the Trpv1 Receptor

E0063 Cardioprotection by Ischaemic Preconditioning is Lost in Isolated Diabetic Hearts: Role of Transient Receptor Potential Vanilloid 1

Sympathetic Nerve Innervation and Metabolism in Ischemic Myocardium in Response to Remote Ischemic Conditioning

Remote cardioprotection by direct peripheral nerve stimulation and topical capsaicin is mediated by circulating humoral factors

Effect Of Remote Ischemic Postconditioning On An Intracerebral Hemorrhage Stroke Model In Rats

Remote limb ischemic postconditioning promotes motor function recovery in a rat model of ischemic stroke via the up-regulation of endogenous tissue kallikrein

Dual activation of AKT kinase and STAT-3 kinase is involved in the cardioprotection by remote limb ischemic postconditionin in rats

Remote Conditioning by Rhythmic Compression of Limbs Ameliorated Myocardial Infarction by Downregulation of Inflammation via A2 Adenosine Receptors

Transient cardioprotective effects of remote ischemic postconditioning on non-reperfused myocardial infarction: longitudinal evaluation study in pigs

[Myocardial Protection of Remote Ischemic Postconditioning During Primary Percutaneous Coronary Intervention in Patients with Acute ST-segment Elevation Myocardial Infarction].